Hypopigmentation associated with an adenovirus-mediated gp 100/MART-1-transduced dendritic cell vaccine for metastatic melanoma. (Observation)

MLA

Tsao, Hensin, et al. “Hypopigmentation Associated with an Adenovirus-Mediated Gp 100/MART-1-Transduced Dendritic Cell Vaccine for Metastatic Melanoma. (Observation).” Archives of Dermatology, vol. 138, no. 6, June 2002, p. 799. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.88572998&authtype=sso&custid=ns315887.

APA

Tsao, H., Millman, P., Linette, G. P., Hodi, F. S., Sober, A. J., Goldberg, M. A., & Haluska, F. G. (2002, June 1). Hypopigmentation associated with an adenovirus-mediated gp 100/MART-1-transduced dendritic cell vaccine for metastatic melanoma. (Observation). Archives of Dermatology, 138(6), 799.

Chicago

Tsao, Hensin, Peri Millman, Gerald P. Linette, F. Stephen Hodi, Arthur J. Sober, Mark A. Goldberg, and Frank G. Haluska. 2002. “Hypopigmentation Associated with an Adenovirus-Mediated Gp 100/MART-1-Transduced Dendritic Cell Vaccine for Metastatic Melanoma. (Observation).” Archives of Dermatology, June 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.88572998&authtype=sso&custid=ns315887.